Publications by authors named "Paola Reitano"
Background: Cladribine tablets are a highly effective option for the treatment of relapsingremitting multiple sclerosis (RRMS).
Objective: The study aims to evaluate the effectiveness of cladribine in a real-world setting.
Methods: This prospective real-world study consecutively screened all RRMS patients from seven different MS centers in Sicily (Italy) who completed the 2-year treatment course of cladribine tablets in the period between 11 March 2019 and 31 October 2021.
Article Synopsis
- The study aimed to estimate the prevalence of isolated rapid eye movement sleep behavior disorder (RBD) in Catania, Italy, due to limited previous research on the topic.
- A structured approach involved screening 1,524 individuals using a specific questionnaire, conducting phone interviews, and providing clinical examinations to confirm diagnoses.
- The findings showed a prevalence of 2.36% for probable RBD and 0.26% for definite RBD, indicating that isolated RBD is relatively uncommon in the general population, consistent with existing research.